Compare ASUR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASUR | EMBC |
|---|---|---|
| Founded | 1985 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.4M | 199.9M |
| IPO Year | 1996 | 2021 |
| Metric | ASUR | EMBC |
|---|---|---|
| Price | $8.58 | $3.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $14.33 | ★ $18.50 |
| AVG Volume (30 Days) | 88.1K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.67 |
| Revenue | ★ $88,952,000.00 | N/A |
| Revenue This Year | $16.33 | $1.17 |
| Revenue Next Year | $9.20 | N/A |
| P/E Ratio | ★ N/A | $5.43 |
| Revenue Growth | ★ 63.39 | N/A |
| 52 Week Low | $6.80 | $2.77 |
| 52 Week High | $10.20 | $15.55 |
| Indicator | ASUR | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 59.82 |
| Support Level | $7.86 | $3.07 |
| Resistance Level | $9.82 | $9.45 |
| Average True Range (ATR) | 0.46 | 0.15 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 80.48 | 71.39 |
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.